Filing Details

Accession Number:
0001127602-22-024599
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-01 16:30:40
Reporting Period:
2022-10-28
Accepted Time:
2022-11-01 16:30:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
310158 Merck & Co. Inc. MRK Pharmaceutical Preparations (2834) 221918501
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1916310 Jacobus Johannes Oosthuizen Merck &Amp; Co., Inc.
126 Lincoln Avenue
Rahway NJ 07065
President, U.s. Market No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-10-28 3,633 $100.21 10,881 No 4 S Direct
Common Stock Acquisiton 2022-10-30 913 $100.77 11,794 No 4 M Direct
Common Stock Disposition 2022-10-30 450 $100.77 11,344 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2022-10-30 913 $0.00 913 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
915 2021-10-30 2023-10-30 No 4 M Direct
Footnotes
  1. Holdings include shares acquired in dividend reinvestment transactions.
  2. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  3. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2021, 10/30/2022 and 10/30/2023.